Cargando…
GABA and Combined GABA with GAD65-Alum Treatment Alters Th1 Cytokine Responses of PBMCs from Children with Recent-Onset Type 1 Diabetes
Type 1 diabetes (T1D) is an autoimmune disease culminating in the destruction of insulin-producing pancreatic cells. There is a need for the development of novel antigen-specific strategies to delay cell destruction, including combinatorial strategies that do not elicit systemic immunosuppression. G...
Autores principales: | Heath, Katie E., Feduska, Joseph M., Taylor, Jared P., Houp, Julie A., Botta, Davide, Lund, Frances E., Mick, Gail J., McGwin, Gerald, McCormick, Kenneth L., Tse, Hubert M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377053/ https://www.ncbi.nlm.nih.gov/pubmed/37509587 http://dx.doi.org/10.3390/biomedicines11071948 |
Ejemplares similares
-
A randomized trial of oral gamma aminobutyric acid (GABA) or the combination of GABA with glutamic acid decarboxylase (GAD) on pancreatic islet endocrine function in children with newly diagnosed type 1 diabetes
por: Martin, Alexandra, et al.
Publicado: (2022) -
Immunoreactivity for GABA, GAD65, GAD67 and Bestrophin-1 in the Meninges and the Choroid Plexus: Implications for Non-Neuronal Sources for GABA in the Developing Mouse Brain
por: Tochitani, Shiro, et al.
Publicado: (2013) -
Effect of simultaneous vaccination with H1N1 and GAD-alum on GAD(65)-induced immune response
por: Tavira, Beatriz, et al.
Publicado: (2017) -
Combinational Spinal GAD65 Gene Delivery and Systemic GABA-Mimetic Treatment for Modulation of Spasticity
por: Kakinohana, Osamu, et al.
Publicado: (2012) -
Cognitive Impairment and the correlation with genetic Expression of GAD67, Gad65 and GABA beta2 Using Human Induced Pluripotent Stem Cells
por: Khalifa, D., et al.
Publicado: (2022)